These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 758988)

  • 1. Angiography for study of lipid-lowering therapy.
    Blankenhorn DH; Sanmarco ME
    Circulation; 1979 Feb; 59(2):212-4. PubMed ID: 758988
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
    Kuo PT; Hayase K; Kostis JB; Moreyra AE
    Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ; Fallat RW; Mellies M; Tsang RC
    Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
    LaRosa J
    Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
    Nash DT; Gensini G; Esente P
    Int J Cardiol; 1982; 2(1):43-55. PubMed ID: 7129689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypercholesterolemia. Can it retard atherogenesis?
    Untereker WJ
    Int J Cardiol; 1982; 2(1):57-9. PubMed ID: 7129690
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol, colestipol and coronary heart disease.
    Stone NJ
    J Chronic Dis; 1978 Jan; 31(1):1-3. PubMed ID: 346595
    [No Abstract]   [Full Text] [Related]  

  • 13. Bile acid sequestrants and hyperlipidaemia.
    Lancet; 1988 Jan; 1(8579):220-1. PubMed ID: 2893044
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary.
    Cooper EE; Michel AM
    Adv Exp Med Biol; 1977; 82():191-4. PubMed ID: 920358
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    Faruqui AM; Thurmond MS; Wenger J; Wenger NK
    J Pak Med Assoc; 1981 Nov; 31(11):241-5. PubMed ID: 6802993
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating hyperlipidemia to provide salutary effect on coronary artery disease.
    Kuo PT
    Chest; 1984 Apr; 85(4):455-6. PubMed ID: 6705571
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
    Kuo PT; Kostis JB; Moreyra AE; Hayes JA
    Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
    Dorr AE; Gundersen K; Schneider JC; Spencer TW; Martin WB
    J Chronic Dis; 1978 Jan; 31(1):5-14. PubMed ID: 346598
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins.
    Witztum JL; Schonfeld G; Weidman SW; Giese WE; Dillingham MA
    Metabolism; 1979 Mar; 28(3):221-9. PubMed ID: 216884
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with a new cholesterolemia-lowering resin, Colestipol (U-26, 597 A. Upjohn)].
    Muls E; Lemmens P
    Acta Clin Belg; 1975; 30(5):409-14. PubMed ID: 1221747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.